Search
for
Sort by
Research 601–630 of 1000+
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Polycystic Ovary Syndrome
- Molecular basis of hypohidrotic ectodermal dysplasia: an update
- Safety of testosterone treatment in postmenopausal women
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- Polycystic ovary syndrome and impact on health
- Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- How should postmenopausal androgen excess be evaluated?
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Role of -catenin in Epidermal Stem Cell Expansion, Lineage Selection, and Cancer
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- STEROIDS AND STEROID-LIKE COMPOUNDS
- How to diagnose a lipodystrophy syndrome
- The therapeutic use of androgens in women
- Safety of testosterone use in women
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Testosterone therapy for sexual dysfunction in postmenopausal women
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Acne in the adult female patient: a practical approach
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats